Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/20470Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Pentheroudakis, G. | en |
| dc.contributor.author | Pavlidis, N. | en |
| dc.date.accessioned | 2015-11-24T19:07:48Z | - |
| dc.date.available | 2015-11-24T19:07:48Z | - |
| dc.identifier.issn | 0305-7372 | - |
| dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/20470 | - |
| dc.rights | Default Licence | - |
| dc.subject | Adolescent | en |
| dc.subject | Antineoplastic Agents/*adverse effects | en |
| dc.subject | Drug Toxicity/chemically induced/*epidemiology | en |
| dc.subject | Humans | en |
| dc.subject | Incidence | en |
| dc.subject | Neoplasms/*drug therapy/mortality | en |
| dc.subject | Risk Factors | en |
| dc.subject | Survival Rate | en |
| dc.subject | World Health | en |
| dc.title | Late toxicity in survivors from adolescent cancers | en |
| heal.type | journalArticle | - |
| heal.type.en | Journal article | en |
| heal.type.el | Άρθρο Περιοδικού | el |
| heal.identifier.primary | 10.1016/j.ctrv.2007.06.002 | - |
| heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/17640814 | - |
| heal.identifier.secondary | http://ac.els-cdn.com/S0305737207000771/1-s2.0-S0305737207000771-main.pdf?_tid=063940c20679767033e72ac7de475b4d&acdnat=1333955094_2b46f507792b56e1f4efe68de84aba77 | - |
| heal.language | en | - |
| heal.access | campus | - |
| heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
| heal.publicationDate | 2007 | - |
| heal.abstract | Nowadays three quarters of adolescents with cancer are cured but half of them experience a late toxic effect of antineoplastic therapy that interferes with their physical and psychosocial health. This review recapitulates late effects associated with radiation therapy, chemotherapy and surgery, reviews risk factors and prognosis and suggests follow-up and management strategies, excluding fertility issues. Adolescents with cancer should be the focus of active clinical research for the optimisation of antineoplastic treatment as well as for breakthroughs in the follow-up, prevention and management of toxic effects. | en |
| heal.journalName | Cancer Treat Rev | en |
| heal.journalType | peer-reviewed | - |
| heal.fullTextAvailability | TRUE | - |
| Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Pentheroudakis-2007-Late toxicity in sur.pdf | 181.73 kB | Adobe PDF | View/Open Request a copy |
This item is licensed under a Creative Commons License
